Internal Medicine, Medical Oncology · Saint Louis, MO
NPI
1023034337
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
4500 Forest Park Ave, Div Im Bone Marrow Transplant, 5th, 6th, 8th Fl
Saint Louis, MO, 63108
Phone (314) 454-8304
Groups this clinician bills Medicare through
Medicare paid, 2024
$877K
35,971 services
Medicare patients, 2024
358
Average age 72
Drug cost, 2024
$8.1M
2,266 prescriptions
Company payments, 2025
$13K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ravi Vij was code J9144 (injection, daratumumab, 10 mg and hyaluronidase-fihj), 6,840 times for 24 patients. In total Ravi Vij billed 35,971 services in 123 codes, and Medicare paid $877K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 6,840 | 24 | $38.36 | $262K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 2,250 | 13 | $0.11 | $238 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 830 | 40 | $0.09 | $76.73 |
| 36415 Venipuncture Blood Collection | Office | 287 | 88 | $8.65 | $2,483 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 260 | 21 | $0.81 | $210 |
| 99214 Office E&M - Established | Office | 220 | 83 | $97.31 | $21K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 170 | 14 | $0.28 | $47.89 |
| 99213 Office E&M - Established | Office | 162 | 66 | $68.68 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 105 | 19 | $90.85 | $9,539 |
| 96375 Injection Administration | Office | 105 | 53 | $11.15 | $1,171 |
| 96413 Chemotherapy Administration | Office | 103 | 68 | $95.25 | $9,811 |
| 96367 Intravenous Infusion, Hydration | Office | 84 | 44 | $21.21 | $1,782 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 64 | 15 | $5.37 | $344 |
| 96401 Chemotherapy Administration | Office | 62 | 36 | $52.52 | $3,256 |
| 96372 Injection Administration | Office | 52 | 38 | $10.82 | $563 |
By year: 2022 $1.8M for 91,242 services; 2023 $2.3M for 101,735 services; 2024 $877K for 35,971 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 287 | 88 | $8.65 | $2,483 |
Medicare prescription drug claims, 2024
In 2024, the drug Ravi Vij prescribed most often to Medicare patients was Acyclovir, with 256 prescriptions and refills. In total Ravi Vij wrote 2,266 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 256 | 450 | 66 | $6,395 |
| Lenalidomide Generic | 155 | 155 | 17 | $2.2M |
| Dexamethasone Generic | 135 | 147 | 40 | $2,211 |
| Pomalyst Pomalidomide | 134 | 134 | 22 | $2.9M |
| Valacyclovir Valacyclovir Hcl | 129 | 229 | 27 | $4,405 |
| Revlimid Lenalidomide | 112 | 112 | 19 | $2.0M |
| Gabapentin Generic | 96 | 132 | 24 | $1,412 |
| Oxycodone Hcl Generic | 89 | 89 | 38 | $2,429 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 87 | 124 | 20 | $326 |
| Oxycontin Oxycodone Hcl | 64 | 64 | 11 | $46K |
| Prochlorperazine Maleate Generic | 54 | 54 | 31 | $1,599 |
| Zolpidem Tartrate Generic | 42 | 42 | 11 | $200 |
| Famotidine Generic | 42 | 74 | 22 | $237 |
| Pregabalin Generic | 42 | 44 | 11 | $396 |
| Morphine Sulfate Er Morphine Sulfate | 32 | 32 | 11 | $771 |
Brand drugs: - claims; generic drugs: 1,752 claims; opioid claims: 284.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ravi Vij $13K ($11K in general payments such as food, travel and fees and $1,207 for research) from 18 companies. The largest payer was Janssen Biotech, Inc. with $3,990.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 7 | $3,990 |
| Pfizer Inc. PFE | 2 | $3,055 |
| Genzyme Corporation SNY | 1 | $1,250 |
| F. Hoffmann-La Roche AG ROG.SW | 2 | $1,207 |
| Abbvie Inc. ABBV | 3 | $731 |
| Deciphera Pharmaceuticals Inc. | 1 | $620 |
| BeiGene, Ltd. ONC | 1 | $500 |
| BeOne Medicines Ltd. ONC | 1 | $458 |
| Legend Biotech USA Inc. LEGN | 2 | $285 |
| BeOne Medicines USA, Inc. ONC | 2 | $267 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.